Login / Signup

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.

Efstathios KastritisIoannis V KostopoulosEvangelos TerposBruno PaivaDespina FotiouMaria GavriatopoulouNikolaos KanelliasDimitrios C ZiogasMaria RoussouMagdalini MigkouEvangelos Eleutherakis-PapaiakovouIoannis P TrougakosOurania TsitsilonisMeletios A Dimopoulos
Published in: Blood cancer journal (2018)
Keyphrases
  • flow cytometry
  • multiple myeloma